
An antiviral drug used to treat high-risk COVID-19 patients may also benefit patients with long COVID, researchers say. Paxlovid has U.S. Food and Drug Administration emergency use authorization to treat COVID-19 patients who are older than 65 or have underlying health conditions such as obesity, diabetes or cancer. The pill includes the antivirals nirmatrelvir and… read on > read on >